COSTANZO, ANTONIO
 Distribuzione geografica
Continente #
AS - Asia 939
NA - Nord America 641
EU - Europa 565
SA - Sud America 114
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.294
Nazione #
US - Stati Uniti d'America 604
SG - Singapore 317
CN - Cina 267
IT - Italia 207
BR - Brasile 100
BD - Bangladesh 98
DE - Germania 98
VN - Vietnam 96
HK - Hong Kong 70
FR - Francia 46
GB - Regno Unito 44
RU - Federazione Russa 40
IN - India 32
NL - Olanda 26
FI - Finlandia 25
CA - Canada 22
SE - Svezia 18
ES - Italia 17
PL - Polonia 14
CI - Costa d'Avorio 13
KR - Corea 13
ID - Indonesia 10
JP - Giappone 10
MX - Messico 8
ZA - Sudafrica 7
IE - Irlanda 6
TN - Tunisia 6
AZ - Azerbaigian 5
BE - Belgio 5
DK - Danimarca 5
TR - Turchia 5
AR - Argentina 4
UA - Ucraina 4
IQ - Iraq 3
PT - Portogallo 3
RO - Romania 3
AO - Angola 2
BO - Bolivia 2
CO - Colombia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
NP - Nepal 2
PK - Pakistan 2
PY - Paraguay 2
AU - Australia 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
IR - Iran 1
JO - Giordania 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PR - Porto Rico 1
RS - Serbia 1
SA - Arabia Saudita 1
SR - Suriname 1
UZ - Uzbekistan 1
VE - Venezuela 1
VI - Stati Uniti Isole Vergini 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.294
Città #
Singapore 142
Ashburn 129
Hefei 75
Frankfurt am Main 71
San Jose 71
Milan 64
Hong Kong 47
Dallas 39
Beijing 38
Los Angeles 35
Ho Chi Minh City 34
Council Bluffs 29
New York 25
Hanoi 24
Bengaluru 22
Lauterbourg 21
Munich 21
Chandler 20
Rome 17
Boardman 15
Buffalo 15
Abidjan 13
Southend 13
Guangzhou 12
Atlanta 11
Helsinki 11
Moscow 11
Seoul 11
São Paulo 11
Warsaw 11
Lappeenranta 10
Santa Clara 10
Orem 9
Rio de Janeiro 8
Tokyo 8
Johannesburg 7
Madrid 7
Naples 7
Denver 6
Dublin 6
Montreal 6
Roubaix 6
Shanghai 6
Amsterdam 5
Baku 5
Ben Arous 5
Changsha 5
Falls Church 5
Jakarta 5
The Dalles 5
Washington 5
Wilmington 5
Bexley 4
Cagliari 4
Katy 4
Manchester 4
Monza 4
Princeton 4
Seattle 4
Stockholm 4
Toronto 4
Turku 4
Ann Arbor 3
Brooklyn 3
Brussels 3
Calgary 3
City of London 3
Hangzhou 3
Houston 3
Hyderabad 3
Jinan 3
London 3
Mexico City 3
Miano 3
Montichiari 3
Nuremberg 3
Pioltello 3
Santos 3
Seregno 3
Shenyang 3
Thái Bình 3
Ascoli Piceno 2
Belo Horizonte 2
Bologna 2
Boston 2
Bucharest 2
Campi Bisenzio 2
Carpi 2
Cochabamba 2
Columbus 2
Da Nang 2
Dearborn 2
Delhi 2
Des Moines 2
Florence 2
Fortaleza 2
Haiphong 2
Harbin 2
Holte 2
Hải Dương 2
Totale 1.334
Nome #
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis 280
Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study 164
Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study 151
Measuring psoriatic disease in clinical practice. An expert opinion position paper 130
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis) 128
Literature review and expert opinion on diagnosis and current management of generalized pustular psoriasis 118
Long-term effectiveness and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: a five-year multicenter retrospective study—IL PSO (Italian Landscape Psoriasis) 116
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience 114
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options 104
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 102
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis) 100
The RMEisk of Candidiasis During Treatment with Bimekizumab for the Management of Plaque Psoriasis: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 95
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 91
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis) 89
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis) 88
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series 81
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA-IL PSO (Italian Landscape Psoriasis) 78
A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis) 77
Association between maternal dupilumab exposure and pregnancy outcomes in patients with moderate-to-severe atopic dermatitis: A nationwide retrospective cohort study 76
Pustular psoriasis with a focus on generalized pustular psoriasis: classification and diagnostic criteria. An Italian expert consensus 59
Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study 43
What is 'chronic' pustular psoriasis? Identifying candidates for long-term subcutaneous spesolimab treatment 33
Five-year drug survival of dupilumab in atopic dermatitis: Italian landscape AD real-world study 32
Real-World Effectiveness and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Italian Study Focusing on Head and Neck Involvement 17
null 14
Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis) 14
null 12
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study 4
Selective IL-23 Inhibition in Conventional Treatment-Refractory Pyoderma Gangrenosum: A Multicenter, Retrospective Study 2
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort Study 1
Totale 2.413
Categoria #
all - tutte 5.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 1 0 0 1 3 3 2 1 3 1 2 10
2022/202372 7 9 4 3 2 15 1 5 8 0 13 5
2023/202496 8 3 6 4 11 4 13 7 5 14 8 13
2024/2025364 7 16 11 16 10 7 32 17 22 38 31 157
2025/20261.805 181 181 168 196 173 69 155 97 175 116 225 69
Totale 2.413